Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site

Site Search

Search results for: CTCAE

46 results found.

5 pages of results.
Sorted by relevance / Sort by date
Instructions for Building “Possible Side Effects” Tables for Informed Consent Forms - Investigational Agents (Single Agents)
... Consent, Investigational, Single Agents, NCI, National Cancer Institute, CAEPR, CTCAE, Terms, Symptoms ...
Terms matched: 1  -  Score: 10  -  9 Nov 2015  -  URL: https://ctep.cancer.gov/protocolDevelopment/docs/Instructions-Tables-Investigational.doc
... CTCAE v3.0 and Lay Term Mapping Document ...
Terms matched: 1  -  Score: 10  -  9 Nov 2015  -  URL: https://ctep.cancer.gov/forms/docs/ctcae_laypublish.xls
... X mg/m2, and not as a percent of the previous dose use values for CTCAE grades consistent with the actual definition and, finally, this one is tricky but ...
Terms matched: 1  -  Score: 5  -  31 Jul 2009  -  URL: https://ctep.cancer.gov/branches/pmb/inside_pmb/aug2009.pdf
... : Provide the link for A number of investigators still have pending Special 1. CTCAE v 3.0. Exceptions (SPEX) paperwork with CTEP. Once 2. PMB's ...
Terms matched: 1  -  Score: 4  -  30 Jan 2009  -  URL: https://ctep.cancer.gov/branches/pmb/inside_pmb/feb2009.pdf
... NCI Asymptomatic, transient Recurrent or persistent (> 24 Requiring more than one Life-threatening CTCAE ver 3.0 (< 24 hrs) increase by >20 hrs) or symptomatic ...
Terms matched: 1  -  Score: 4  -  31 Oct 2008  -  URL: https://ctep.cancer.gov/branches/pmb/inside_pmb/nov2008.pdf
... be routinely questioned about potential neurotoxicity, and undergo immediate dose reduction for neurotoxicity >CTCAE grade 1. In addition, delivery of IV paclitaxel at a reduced dose ( ...
Terms matched: 1  -  Score: 4  -  4 Jan 2006  -  URL: https://ctep.cancer.gov/highlights/docs/clin_annc_010506.pdf
Result Pages: << Previous 1 2 3 4 5